Ligand to Report Second Quarter 2026 Financial Results on August 6, 2026

manilatimes.net · 2026-07-23

JUPITER, Fla., July 23, 2026 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that it will report second quarter 2026 financial results on Thursday, August 6, 2026. The company will hold a conference call beginning at 8:30 a.m. Eastern time to discuss the results and provide a general business update.

TickrTrends take: Ligand Pharmaceuticals is scheduled to release its second quarter 2026 financial results on August 6, 2026, providing investors with updated operational and financial metrics for assessment. Given that TickrTrends currently rates LGND as overvalued within the Healthcare sector, the August earnings report will be a key opportunity to evaluate whether the company's actual financial performance supports its current market valuation. Valuation-focused observers should monitor revenue trends, profitability margins, and guidance updates to determine if recent market pricing has properly reflected the company's underlying fundamentals.

Read the full story at manilatimes.net →